This paper, Co authored with @juliansavulescu and @G_Owen_Schaefer is out. Here, we argue that across a variety of public-facing contexts, we should attribute bias to an algorithm only if it is publicly justifiable that its unselective deployment in a given context would be wrong
CBmE is excited to announce the launch of it's very own podcast: CBmE & U! This podcast is for anybody interested in learning about and debating #bioethics.
Find it online at:
https://t.co/3ytlX2Dx3C
Or on a streaming service that suits you:
https://t.co/nci8uqEdRQ
Consent and Risk Communication in Clinical Trials
Shou Yiyun
part of our event "Hot Topics in Consent for Research – #AI and Risk in #ClinicalTrials", on Friday 28 June 2024, at @NUS_CBmE#Bioethics#ResearchEthics
Hot Topics in Consent for Research – #AI and Risk in #ClinicalTrials
Welcome & Introduction by Sumytra Menon
Friday 28 June 2024, at @NUS_CBmE#Bioethics
HIRING ➡️ 2 Research Fellows (PostDoc) on the https://t.co/lPLGoCFa9a project
RESEARCH ➡️ clinical & research ethics, as well as evaluation of educational programmes and ethical guidelines
POSITION ➡️ 2 year, Singapore
INFO ➡️ https://t.co/aJQpZGG23s .
HIRING ➡️ Research Associate (master’s) for https://t.co/lPLGoCFa9a
RESEARCH ➡️ may include Health Information Act, patients with renal failure, end-of-life, risk in complex treatment decision-making
POSITION ➡️ 1 year (renewable), Singapore
INFO ➡️ https://t.co/900SRInmFc .